Vita Coco vs Westrock Coffee
COCO and WEST side by side, both in beverages. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How COCO and WEST compare
Vita Coco is the larger company, worth 4.4 times as much as Westrock Coffee ($3.7B against $839M).
Vita Coco grew revenue faster over the last twelve months (26.0% versus 16.3% for Westrock Coffee).
Vita Coco keeps more of each dollar of sales as profit, with a net margin of 15.7% compared with −4.4% at Westrock Coffee.
Vita Coco scores higher on the StockData Score (21 against 5 for Westrock Coffee), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | COCO | WEST |
|---|---|---|
| Size and price | ||
| Market cap | $3.7B | $839M |
| Share price | $65.31 | $8.59 |
| Change, 1 year | 56.6% | 106% |
| Change, 5 years | 315% | −11.9% |
| Beta (5Y) | 1.11 | 0.58 |
| Employees | 336 | 1,393 |
| StockData Score | ||
| Total score | 21 (better) | 5 |
| Valuation score | 3 (better) | 2 |
| Growth score | 6 (better) | 2 |
| Performance score | 6 (better) | 1 |
| Health score | 6 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 32.8× | – |
| P/S | 4.9× | 0.7× (better) |
| P/B | 8.7× | – |
| EV/EBITDA | 23.0× | 20.1× (better) |
| P/FCF | 25.9× (better) | 27.8× |
| PEG | 0.32 | – |
| FCF yield | 3.9% (better) | 3.6% |
| Fair value | $66.64 | – |
| Margin of safety | 2.0% | – |
| Growth | ||
| Revenue growth (TTM) | 26.0% (better) | 16.3% |
| Revenue growth, 5Y average | 14.4% | 16.6% (better) |
| Net income growth (TTM) | 74.2% | – |
| EPS growth (TTM) | 73.0% | – |
| EPS growth, 5Y average | 16.3% | – |
| Profitability | ||
| Gross margin | 41.0% (better) | 13.1% |
| Operating margin | 19.9% (better) | −0.30% |
| Net margin | 15.7% (better) | −4.4% |
| FCF margin | 18.8% (better) | 2.4% |
| Return on equity | 32.0% | – |
| Return on invested capital | 59.8% (better) | −0.71% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Net debt / EBITDA | – | 6.49 |
| Interest coverage | – | −0.1× |
| Current ratio | 2.48 (better) | 0.89 |
| Altman Z-score | 11.32 (better) | 0.93 |
| Piotroski F-score | 5 (better) | 2 |
| Dividends and buybacks | ||
| Buyback yield | 1.7% | – |
| Shareholder yield | 1.7% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 86.8% | 49.5% |
| Held by insiders | 22.7% | 57.9% |
| Insider net buying, 12 months | −$72.2M | $1.1M (better) |
| Short interest, % of float | 16.1% | 13.5% |
Go deeper
- COCO stock overview
- COCO income statement
- COCO valuation and score
- WEST stock overview
- WEST income statement
- WEST valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.